Abstract
Purpose: HDR brachytherapy has been widely used in the past 2 decades in the management of cervical cancer. ABS and GEC-ESTRO HDR guidelines are widely used for optimal treatment planning. The purpose of this study is to generate a comprehensive predictive model for target tissue and critical structure dosimetry in the application of HDR brachytherapy for cervical cancer using ABS guidelines.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
